Costotransverse joint injections are a minimally invasive diagnostic and therapeutic procedure used to treat pain originating from the thoracic spine. The costotransverse joints are formed between the ribs and the transverse processes of the thoracic vertebrae and play an important role in the stability and mobility of the thoracic cage during breathing and trunk movements.
The procedure involves the targeted injection of a local anesthetic, with or without a corticosteroid, into the affected joint or surrounding tissues. The goal is to reduce inflammation, relieve pain, and improve the patient’s functional capacity. In addition, the patient's response to the injection can help identify the precise source of the symptoms.
Costotransverse joint injections are indicated for degenerative joint changes, arthritis, thoracic spine injuries, overuse syndromes, and chronic thoracic pain that does not respond adequately to conservative treatment. They are often incorporated into a comprehensive treatment plan that includes physiotherapy, therapeutic exercise, and ergonomic interventions.
When performed by a qualified specialist under fluoroscopic or ultrasound guidance, costotransverse joint injections are considered safe and well tolerated. They can provide significant pain relief and contribute to improved quality of life and daily function.